Compare RDI & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDI | NXPL |
|---|---|---|
| Founded | 1937 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Movies/Entertainment | Telecommunications Equipment |
| Sector | Consumer Discretionary | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.2M | 25.6M |
| IPO Year | N/A | N/A |
| Metric | RDI | NXPL |
|---|---|---|
| Price | $1.04 | $0.60 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 469.8K | 143.4K |
| Earning Date | 11-14-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $211,292,000.00 | $57,151,000.00 |
| Revenue This Year | $1.06 | N/A |
| Revenue Next Year | $10.97 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 7.11 | N/A |
| 52 Week Low | $1.02 | $0.43 |
| 52 Week High | $1.87 | $2.30 |
| Indicator | RDI | NXPL |
|---|---|---|
| Relative Strength Index (RSI) | 24.54 | 42.37 |
| Support Level | $1.08 | $0.59 |
| Resistance Level | $1.27 | $0.70 |
| Average True Range (ATR) | 0.07 | 0.06 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 6.45 | 14.23 |
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.
NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.